Coronavirus Update: RECOVERY Finds Kaletra Ineffective, Indian Company Joins Vaccine Race
Plus: Could Tweaks Boost Remdesivir Benefits?
A third set of authoritative results from UK trial ruled out use of AbbVie's HIV combination, plus Bharat Biotech to launch Phase I vaccine trials.
